Online Introduction to Drug Discovery: From Idea to Clinical Candidate


Session 1 9:00 - 11:00 | Session 2 14:00 - 16:00 BOTH DAYS Wednesday 24 November - Thursday 25 November 2021

Dates Wednesday, November 24, 2021 to Thursday, November 25, 2021 - Download as vCalendar
Event Times: 09:00 to 16:00
Venue Online
Contact Name One Nucleus
Email training@onenucleus.com
Contact Phone 01223 896456
Website Event website

Event details:

Audience

Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers and general managers.

 
Duration

A two day course.

 
Objectives

The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely: Drug Discovery Biology, ADMET/PK/PD, Medicinal Chemistry, Informatics/Virtual technologies and how these contributions are phased over time and integrated to generate a drug suitable for clinical trials.

The focus is on small molecule drugs with comparisons made with biologics. Based on real-world experience and practical realities, attendees travel step-by-step along a typical drug discovery path, namely: Initiating Idea -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination. 

Essential related topics include drug discovery technology platforms, drug structural-functional quality attributes and Project management tools, namely Target Product Profile (TPP) use.

Key technology and infrastructure requirements are also covered in the course.

 
Costs

Gold Members: £357+ VAT
Silver Members: £433.50 + VAT
Non-members: £510 + VAT

One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.